Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Ibrutinib
100%
Cardiovascular Toxicity
100%
Cardiovascular Disease
33%
Chronic Kidney Disease
16%
Patient Characteristics
16%
Heart Disease
16%
Logistic Regression Analysis
8%
Side Effect
8%
Clinical Trial
8%
Overall Survival
8%
Cardiovascular System
8%
Disease Exacerbation
8%
Event Free Survival
8%
Systolic Blood Pressure
8%
Blood Pressure
8%
Diastolic Blood Pressure
8%
Tobacco Use
8%
Patient with Heart Disease
8%
Antihypertensive Agent
8%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
100%
Cardiovascular Toxicity
100%
Ibrutinib
100%
Cardiovascular Disease
33%
Heart Disease
25%
Chronic Kidney Failure
16%
Side Effect
8%
Overall Survival
8%
Clinical Trial
8%
Disease Exacerbation
8%
Antihypertensive Agent
8%
Event Free Survival
8%
Keyphrases
Cardiovascular Survival
7%